Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17393785rdf:typepubmed:Citationlld:pubmed
pubmed-article:17393785lifeskim:mentionsumls-concept:C0025344lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C0242350lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C1318700lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C2347804lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C1561960lld:lifeskim
pubmed-article:17393785lifeskim:mentionsumls-concept:C1948053lld:lifeskim
pubmed-article:17393785pubmed:issue3lld:pubmed
pubmed-article:17393785pubmed:dateCreated2007-3-30lld:pubmed
pubmed-article:17393785pubmed:abstractTextTo observe and compare the effects and adverse events of the three phosphodiesterase type 5 (PDE-5) inhibitors sildenafil, vardenafil and tadalafil used in the same period for the treatment of erectile dysfunction (ED).lld:pubmed
pubmed-article:17393785pubmed:languagechilld:pubmed
pubmed-article:17393785pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393785pubmed:citationSubsetIMlld:pubmed
pubmed-article:17393785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393785pubmed:statusMEDLINElld:pubmed
pubmed-article:17393785pubmed:monthMarlld:pubmed
pubmed-article:17393785pubmed:issn1009-3591lld:pubmed
pubmed-article:17393785pubmed:authorpubmed-author:GaoPingPlld:pubmed
pubmed-article:17393785pubmed:authorpubmed-author:ZhangSi-xiaoS...lld:pubmed
pubmed-article:17393785pubmed:issnTypePrintlld:pubmed
pubmed-article:17393785pubmed:volume13lld:pubmed
pubmed-article:17393785pubmed:ownerNLMlld:pubmed
pubmed-article:17393785pubmed:authorsCompleteYlld:pubmed
pubmed-article:17393785pubmed:pagination226-8lld:pubmed
pubmed-article:17393785pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:meshHeadingpubmed-meshheading:17393785...lld:pubmed
pubmed-article:17393785pubmed:year2007lld:pubmed
pubmed-article:17393785pubmed:articleTitle[Experience of using three phosphodiesterase type 5 inhibitors in the same period for the treatment of erectile dysfunction].lld:pubmed
pubmed-article:17393785pubmed:affiliationDepartment of Urology, Huaxi Hospital, Sichuan University, Chengdu, Sichuan 610041, China.lld:pubmed
pubmed-article:17393785pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17393785pubmed:publicationTypeEnglish Abstractlld:pubmed